Recent evidence suggests that CXCL9 is an important marker of inflammation and plays a key role in the development of age-associated diseases, such as neurodegeneration (82), chronic kidney disease (32), glaucoma (83) and various inflammatory diseases (84–86). The gene discussed is CXCL9; the disease is glaucoma.